SIX6 Human

SIX Homeobox 6 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Molecular Characterization of SIX6 Human

SIX6 Human Recombinant (PRO-1253) is a 269-amino-acid polypeptide (1-246 a.a.) with a 23-amino-acid N-terminal His-tag, produced in Escherichia coli. Key properties include:

PropertySpecification
Molecular Mass30.1 kDa
Purity>90% (SDS-PAGE)
Storage4°C (short-term), -20°C (long-term) with 0.1% carrier protein (e.g., HSA/BSA)
Buffer Composition20 mM Tris-HCl (pH 8.0), 0.2 M NaCl, 40% glycerol, 5 mM DTT, 2 mM EDTA
Biological ActivityValidated in retinal progenitor differentiation assays

Developmental Roles

SIX6, a member of the SIX/Sine oculis homeobox family, regulates:

  • Eye Development: Expressed in optic vesicles and retina precursors; activates retina-specific genes (ALDH1A3, VSX2, LHX2) .

  • Forebrain Patterning: Critical for hypothalamic and pituitary development .

  • Progenitor Maintenance: Interacts with PAX6 and OTX2 to sustain retinal ganglion cell precursors .

Transcriptional Regulation

  • Binds to DNA via its homeodomain, acting as a transcriptional repressor in collaboration with EYA2 and DACH1 .

  • Hypoxia, Wnt, and SHH signaling enhance SIX6+ organoid formation in human pluripotent stem cell models .

Expression Profile

Tissue-specific expression (Human Protein Atlas ):

TissueExpression LevelFunctional Relevance
RetinaHighPhotoreceptor development, optic nerve patterning
HypothalamusModerateNeuroendocrine regulation
Pituitary GlandModerateHormone secretion pathways
Midbrain/HindbrainLowLimited to early developmental stages

Disease Modeling

  • Microphthalmia/Cataracts: Loss-of-function mutations (e.g., c.547delG) disrupt optic vesicle morphogenesis .

  • Pituitary Anomalies: Hemizygous deletions at 14q22.3-q23 correlate with SIX6 haploinsufficiency .

Organoid Studies

CRISPR-generated SIX6-GFP reporter lines enable real-time tracking of retinal differentiation. Key findings:

  • SIX6+ organoids show 100-fold higher SIX6 expression versus controls (p < 10⁻⁶) .

  • Co-expression with POU4F2 (retinal ganglion cell marker) confirms retinogenesis fidelity .

Clinical Mutations and Pathways

Pathogenic variants in SIX6 are linked to:

MutationPhenotypeMechanism
14q22.3-q23 deletionBilateral anophthalmia, pituitary defectsHaploinsufficiency
Missense (p.R98G)Primary open-angle glaucomaImpaired DNA binding
Frameshift (c.331dup)Microphthalmia with colobomaTruncated protein, loss of SIX domain

Technical Considerations for Use

  • Stability: Avoid freeze-thaw cycles; add carrier proteins for long-term storage .

  • Applications: Restricted to in vitro research (e.g., ChIP-seq, reporter assays) per manufacturer guidelines .

Product Specs

Introduction
SIX Homeobox 6 (SIX6) is a protein that plays a crucial role in the development of the eyes and forebrain during embryonic development. It belongs to the SIX/Sine oculis homeobox family and possesses a homeobox DNA-binding domain. SIX6 is involved in providing instructions for the formation of these structures. It is found in various tissues, including the developing and adult retina, hypothalamus, and pituitary regions. Mutations in the SIX6 gene can lead to a condition called microphthalmia isolated with cataract type 2.
Description
This product consists of the SIX6 human recombinant protein, produced in E. coli. It is a single, non-glycosylated polypeptide chain comprising 269 amino acids (specifically, amino acids 1-246). The protein has a molecular weight of 30.1 kDa. For purification purposes, a 23 amino acid His-tag is fused to the N-terminus of SIX6. Proprietary chromatographic techniques are employed to ensure its purity.
Physical Appearance
A clear and sterile solution.
Formulation
The SIX6 protein is provided in a solution with a concentration of 0.5 mg/ml. The solution contains the following components: 20mM Tris-HCl buffer (pH 8.0), 0.2M NaCl, 40% glycerol, 5mM DTT, and 2mM EDTA.
Stability
For short-term storage (up to 2-4 weeks), keep the vial refrigerated at 4°C. For longer storage, freeze the protein solution at -20°C. It is recommended to add a carrier protein, such as HSA or BSA, at a concentration of 0.1% for extended storage. Avoid repeated freezing and thawing cycles to maintain protein integrity.
Purity
The purity of the SIX6 protein is greater than 90%, as determined by SDS-PAGE analysis.
Synonyms
Homeobox protein SIX6, Homeodomain protein OPTX2, Optic homeobox 2, Sine oculis homeobox homolog 6, SIX6, OPTX2, SIX9, OPTX2, MCOPCT2.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMFQLPIL NFSPQQVAGV CETLEESGDV ERLGRFLWSL PVAPAACEAL NKNESVLRAR AIVAFHGGNY RELYHILENH KFTKESHAKL QALWLEAHYQ EAEKLRGRPL GPVDKYRVRK KFPLPRTIWD GEQKTHCFKE RTRNLLREWY LQDPYPNPSK KRELAQATGL TPTQVGNWFK NRRQRDRAAA AKNRLQQQVL SQGSGRALRA EGDGTPEVLG VATSPAASLS SKAATSAISI TSSDSECDI.

Q&A

What is the primary role of SIX6 in human retinal development?

SIX6 plays a crucial role in the differentiation and survival of retinal ganglion cells during human development . Current research indicates that SIX6 functions as a transcription factor that regulates neural progenitor proliferation in the developing retina and optic nerve. The protein functions within a network of transcription factors essential for proper eye formation and maintenance. Experimental approaches using CRISPR-generated reporter systems have demonstrated that SIX6 expression is detectable in early optic vesicle formation, confirming its fundamental role in retinogenesis .

How do SIX6 and SIX1 genes differ in their expression patterns across human tissues?

While both genes belong to the SIX family of homeodomain-containing transcription factors, they exhibit distinct tissue-specific expression patterns. SIX6 shows predominant expression in the developing retina, hypothalamus, and midbrain/hindbrain territories as demonstrated through reporter studies . SIX1, while also expressed in some neural tissues, has broader expression in non-neural tissues. This differential expression reflects their distinct developmental roles and explains why certain SIX6 variants primarily affect ocular tissues while having minimal impact on other systems.

What methodologies are most effective for studying SIX6 expression during human embryonic development?

The development of CRISPR-generated SIX6-GFP and POU4F2-tdTomato reporter systems has revolutionized the study of SIX6 expression patterns. These reporters provide reliable readouts for developing human retina, hypothalamus, and midbrain/hindbrain regions . For studying SIX6 in human development:

  • 3D organoid systems - Human pluripotent stem cells grown in 3D can self-assemble into laminar organized retinas

  • Fluorescence reporter systems - SIX6-GFP allows visualization of gene expression in real-time

  • RNA sequencing - Enables transcriptional profiling of SIX6-expressing tissues

  • Environmental manipulation - Research has shown that hypoxic growth conditions enhance SIX6 expression and promote eye formation

How do specific SIX6 polymorphisms contribute to glaucoma development?

Several SIX6 polymorphisms have been associated with increased glaucoma risk through genome-wide association studies. Particularly significant are:

VariantLocationAssociation StrengthFunctional Consequence
rs10483727SIX1 regionSignificant across ethnicitiesUnknown protein function effect
rs33912345 (Asn141His)SIX6 locusStrong linkage with rs10483727Alters SIX6 protein function

These variants appear to exert age-dependent effects on retinal nerve fiber layer (RNFL) thickness. Research has found that these genetic variants do not cause significant RNFL thinning in younger individuals but manifest their effects later in adult life . The molecular mechanisms likely involve altered transcriptional regulation of genes involved in retinal ganglion cell development and survival.

Why do SIX6 variants show age-dependent effects on retinal nerve fiber layer thickness?

The age-dependent effects of SIX6 variants on RNFL thickness represent a fascinating research question. Studies comparing healthy young adults (mean age 20 years) with older cohorts (mean age 63 years) found that while younger individuals show no significant RNFL thinning with each copy of risk alleles, older individuals exhibited unexpected regional variations . The data suggests:

  • Older adults with SIX6 risk alleles show thicker RNFL in nasal sectors

  • Thinner RNFL was observed in temporal sectors with each copy of the risk allele

  • These patterns suggest that SIX6 variants may influence the normal aging process of retinal ganglion cells or interact with other age-dependent factors

The mechanisms behind this age-dependent manifestation are not fully understood but may involve cumulative stress, delayed neurodegeneration, or interactions with other age-related genetic or environmental factors.

Can compound heterozygous variants in SIX6 produce phenotypes distinct from homozygous variants?

Recent research has identified novel compound heterozygous variants in SIX6 causing optic disc dysplasia and macular abnormalities without coexisting cataract or microphthalmia . These findings expand our understanding of SIX6-related phenotypes. The compound heterozygous state, where different mutations are present on each allele, can produce phenotypes that are distinct from those seen in homozygous variants. This suggests that different functional domains of the SIX6 protein may be affected differently by various mutations, leading to diverse clinical presentations.

Notably, these SIX6-related optic disc abnormalities may be clinically indistinguishable from those seen in PAX2-related Papillo-renal syndrome, highlighting the importance of molecular genetic testing to establish accurate diagnosis .

How can CRISPR-generated reporter systems be optimized for studying SIX6 expression?

CRISPR-generated reporter systems have emerged as powerful tools for visualizing SIX6 expression patterns in developing tissues. Based on recent research, optimization strategies include:

  • Dual reporter systems - The SIX6-GFP/POU4F2-tdTomato dual reporter line labels the entire developing retina and retinal ganglion cells, respectively, allowing simultaneous visualization of multiple cell populations

  • Environmental condition manipulation - Early hypoxic growth conditions enhance SIX6 expression and promote eye formation in reporter systems

  • Signaling pathway modulation - Sequential inhibition of Wnt and activation of sonic hedgehog signaling further enhances SIX6 expression in experimental models

  • Organoid selection strategies - Harvesting specific organoid populations (SIX6+/POU4F2-, SIX6-) allows identification and study of different brain regions including the hypothalamus and midbrain-hindbrain territories

These methodological refinements enable more precise study of SIX6 expression dynamics and functional relationships in developmental contexts.

What transcriptomic approaches best characterize SIX6-expressing tissues during development?

RNA sequencing of SIX6-expressing tissues provides valuable insights into developmental processes. Recent studies demonstrate that:

  • SIX6+ optic vesicles show RNA expression profiles consistent with retinal identity, though ventral diencephalic markers are also present

  • Transcriptional profiling can reliably distinguish between developing human retina, hypothalamus, and midbrain/hindbrain organoids

  • Single-cell RNA sequencing allows identification of cell-type specific expression patterns within SIX6+ tissues

  • Temporal transcriptomic analysis reveals dynamic changes in gene expression during development of SIX6-expressing structures

For meaningful analysis, researchers should combine bulk and single-cell approaches, incorporate time-course designs, and validate findings through reporter visualization or in situ hybridization techniques.

How should researchers distinguish between SIX6-related optic disc dysplasia and other similar phenotypes?

Distinguishing SIX6-related optic disc dysplasia from other similar conditions presents a significant diagnostic challenge. Recent research indicates that SIX6-related dysplastic optic discs may be clinically indistinguishable from those seen in PAX2-related Papillo-renal syndrome . For accurate differentiation:

  • Comprehensive genetic testing - Whole Exome Sequencing (WES) can reveal compound heterozygous or homozygous variants in SIX6

  • Cascade family screening - Testing parents for heterozygous status helps confirm pathogenicity of variants

  • Careful optic disc evaluation - Detection of subtle disc dysplasia is critical in differentiating this rare entity from more common causes of cone dystrophies

  • Extended phenotyping - Assessment for non-ocular abnormalities associated with alternative diagnoses (e.g., renal abnormalities in PAX2-related conditions)

This multi-faceted approach enhances diagnostic accuracy and allows appropriate genetic counseling.

What is the significance of SIX6 variants not found in reference populations?

Novel SIX6 variants absent from reference populations (such as 1000G, ExAC, or ethnicity-specific databases) require careful evaluation to determine pathogenicity . These rare variants may represent:

  • Population-specific genetic variation not yet captured in existing databases

  • Recent de novo mutations with limited population spread

  • Highly penetrant pathogenic variants subject to negative selection

For variants not found in reference populations, researchers should conduct comprehensive functional studies to assess protein expression, DNA binding capacity, transcriptional regulation activity, and protein-protein interactions with known SIX6 partners. These experimental approaches provide critical evidence for variant classification and clinical interpretation.

How might the identification of SIX6 downstream targets advance therapeutic development?

Identifying the complete repertoire of SIX6 transcriptional targets represents a critical research frontier. By characterizing these downstream genes, researchers can:

  • Identify key pathways amenable to therapeutic intervention

  • Develop more precise disease models focusing on specific downstream effectors

  • Design targeted therapies that bypass SIX6 dysfunction by directly modulating critical target genes

Research approaches should combine chromatin immunoprecipitation sequencing (ChIP-seq) with transcriptional profiling of tissues with modified SIX6 expression to build comprehensive gene regulatory networks. This integrative approach will reveal the most promising therapeutic targets within the SIX6 pathway.

What experimental approaches best address the temporal dynamics of SIX6 function?

The age-dependent effects of SIX6 variants highlight the importance of understanding temporal dynamics in SIX6 function. Current research indicates that SIX6 variants exert their influence later in adult life , suggesting complex temporal regulation. To investigate this phenomenon:

  • Longitudinal imaging studies - Track retinal changes in individuals with SIX6 variants across different age groups

  • Inducible gene expression systems - Activate or suppress SIX6 at different developmental timepoints

  • Age-stratified transcriptomic analysis - Compare gene expression profiles between young and old individuals with SIX6 variants

  • Epigenetic profiling - Examine age-dependent changes in chromatin structure and DNA methylation at SIX6 regulatory regions

These approaches will help elucidate how SIX6 function changes throughout the lifespan and may reveal critical windows for therapeutic intervention.

Product Science Overview

Introduction

SIX Homeobox 6 (SIX6) is a member of the SIX/Sine oculis homeobox family, which contains a homeobox DNA-binding domain. This protein is crucial in embryonic development, particularly in the formation of the forebrain and eye development .

Gene and Protein Structure

The SIX6 gene is located on chromosome 14 and is part of a cluster of related genes. The protein encoded by this gene is similar to the Drosophila ‘sine oculis’ gene product . SIX6 Human Recombinant is produced in Escherichia coli (E. coli) and is a single, non-glycosylated polypeptide chain containing 269 amino acids, with a molecular mass of 30.1 kDa . The recombinant protein is fused to a 23 amino acid His-tag at the N-terminus and is purified using proprietary chromatographic techniques .

Biological Function

SIX6 plays a significant role in the development of the retina, hypothalamus, and pituitary regions. It provides essential instructions for the formation of these structures during embryonic development . Defects in the SIX6 gene are associated with microphthalmia isolated with cataract type 2, a condition characterized by abnormally small eyes and cataracts .

Expression and Purification

The recombinant SIX6 protein is expressed in E. coli and is purified to a high degree of purity, greater than 90% as determined by SDS-PAGE . The protein is formulated in a sterile, filtered colorless solution containing 20mM Tris-HCl buffer (pH 8.0), 0.2M NaCl, 40% glycerol, 5mM DTT, and 2mM EDTA .

Storage and Stability

For short-term storage, the SIX6 protein can be kept at 4°C if used within 2-4 weeks. For longer-term storage, it is recommended to store the protein at -20°C, with the addition of a carrier protein such as 0.1% HSA or BSA to prevent multiple freeze-thaw cycles .

Applications

The SIX6 recombinant protein is used in various research applications, including studies on eye development, forebrain formation, and related genetic disorders. It is also valuable in understanding the molecular mechanisms underlying these developmental processes.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.